Share ownership Daiichi Sankyo Company, Limited

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 07:30:00 15/05/2026 BST			5-day change	1st Jan Change
2,574.00 ^JPY	-0.31%		-1.00%	-23.12%

05-11	Daiichi Sankyo Company, Limited, 2026 Earnings Call, May 11, 2026
05-11	Daiichi Sankyo's Attributable Profit Falls 12% in Fiscal Year 2025	MT

Share class: Daiichi Sankyo Company, Limited

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	1,894,350,529	1,818,394,486 ( 95.99 %)	74,697,299 ( 3.943 %)	95.99 %

Major shareholders: Daiichi Sankyo Company, Limited

Name	Equities	%	Valuation
Capital Research & Management Co. (Global Investors) 5.286 %	100,133,610	5.286 %	1 654 M ¥
Nippon Life Insurance Co. 4.263 %	80,757,246	4.263 %	1 334 M ¥
DAIICHI SANKYO COMPANY, LIMITED 3.195 %	60,523,331	3.195 %	1 000 M ¥
Asset Management One Co., Ltd. 2.962 %	56,109,600	2.962 %	927 M ¥
Amova Asset Management Co., Ltd. 2.324 %	44,019,000	2.324 %	727 M ¥
Mizuho Bank Pension Fund 1.32 %	25,014,130	1.32 %	413 M ¥
SHIZUOKA FINANCIAL GROUP,INC. 1.184 %	22,422,790	1.184 %	370 M ¥
MS&AD INSURANCE GROUP HOLDINGS, INC. 0.8752 %	16,580,191	0.8752 %	274 M ¥
Sumitomo Mitsui Banking Pension Fund 0.7342 %	13,908,000	0.7342 %	230 M ¥
Goldman Sachs Asset Management Co., Ltd. (Japan) 0.4846 %	9,179,200	0.4846 %	152 M ¥
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Capital Research & Management Co. (Global Investors) 0.2742 %	5,194,156	0.2742 %	86 M ¥
Madison Asset Management LLC 0.008332 %	157,830	0.008332 %	3 M ¥
Ramirez Asset Management, Inc. 0.007079 %	134,098	0.007079 %	2 M ¥
RhumbLine Advisers LP 0.002482 %	47,014	0.002482 %	776 577 ¥
Yousif Capital Management LLC 0.000901 %	17,066	0.000901 %	281 896 ¥
Arctic Asset Management AS (Sweden) 0.000811 %	15,356	0.000811 %	253 650 ¥
GAMMA Investing LLC 0.000127 %	2,398	0.000127 %	39 610 ¥
PNC Wealth Management LLC 0.000011 %	203	0.000011 %	3 353 ¥
First Command Advisory Services, Inc. 0.000011 %	201	0.000011 %	3 320 ¥
Ancora Private Wealth Advisors LLC 0.000006 %	111	0.000006 %	1 833 ¥
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	18.71%
Daiichi Sankyo Co., Ltd.	3.19%
Other	2.11%
Shizuoka Financial Group, Inc.	1.18%
MS&AD Insurance Group Holdings, Inc.	0.88%
Iyogin Holdings, Inc.	0.41%
Otsuka Holdings Co., Ltd.	0.34%
Tokio Marine Holdings, Inc.	0.31%
Sumitomo Mitsui Financial Group, Inc.	0.25%
Medipal Holdings Corp.	0.14%
Alfresa Holdings Corp.	0.1%
Kissei Pharmaceutical Co., Ltd.	0.06%
Sompo Holdings, Inc.	0.06%
Hitachi Ltd.	0.05%
Toho Holdings Co., Ltd.	0.03%
Vital KSK Holdings, Inc.	0.02%
HOKUYAKU TAKEYAMA Holdings, Inc.	0.01%
Soda Nikka Co., Ltd.	0.01%
Unknown	72.14%

Based on 1000 largest holdings

Geographical origin of shareholders

Japan	19.9%
United States	6.08%
United Kingdom	0.62%
Sweden	0.34%
Belgium	0.14%
Ireland	0.13%
Spain	0.11%
Denmark	0.09%
Hong Kong	0.09%
Finland	0.07%
Germany	0.05%
New Zealand	0.04%
France	0.03%
Luxembourg	0.03%
Australia	0.02%
Netherlands	0.02%
Singapore	0.02%
Canada	0.02%
Italy	0.02%
Norway	0.01%
Austria	0.01%
Liechtenstein	0.01%
South Africa	0.01%
Switzerland	0.01%

Based on 1000 largest holdings

Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Employees

19,765

Sector

Pharmaceuticals

More about the company